Neural precursor cells (NPCs) offer a promising approach for treating demyelinating diseases. However, the cellular dynamics that underlie transplanted NPC-mediated remyelination have not been described. Using two-photon imaging of a newly developed ventral spinal cord preparation and a viral model of demyelination, we describe the motility and intercellular interactions of transplanted mouse NPCs expressing green fluorescent protein (GFP) with damaged axons expressing yellow fluorescent protein (YFP). Our findings reveal focal axonal degeneration that occurs in the ventral side of the spinal cord within 1 wk following intracranial instillation with the neurotropic JHM strain of mouse hepatitis virus (JHMV). Axonal damage precedes extensive demyelination and is characterized by swelling along the length of the axon, loss of YFP signal, and transected appearance. NPCs engrafted into spinal cords of JHMV-infected mice exhibited diminished migration velocities and increased proliferation compared with transplanted cells in noninfected mice. NPCs preferentially accumulated within areas of axonal damage, initiated direct contact with axons, and subsequently expressed the myelin proteolipid protein gene, initiating remyelination. These findings indicate that NPCs transplanted into an inflammatory demyelinating microenvironment participate directly in therapeutic outcome through the wrapping of myelin around damaged neurons.
stem | microscopy | differentiation | myelination | central nervous system M ultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that results in demyelination and axonal loss, culminating in extensive disability through defects in neurologic function (1) . The demyelination that defines MS pathology is progressive over time; however, spontaneous yet transient myelin repair can occur during the course of disease (2) . Currently approved therapies for treating MS are designed to limit immune cell infiltration into the CNS to mute demyelination and impede the emergence of new lesions (3) . Recent studies from our laboratory and others have shown that engraftment of neural precursor cells (NPCs) may provide an important unmet clinical need for MS patients by facilitating sustained remyelination that can restore motor function and ameliorate clinical symptoms associated with demyelinating disease. NPC engraftment is well tolerated in animal models and contributes to clinical recovery associated with remyelination, highlighting the feasibility of using NPCs for treating demyelinating diseases (4) (5) (6) (7) (8) . Indeed, transplantation of human NPCs into the frontal lobes of children with Pelizaeus-Merzbacher disease (PMD), a rare genetic disorder that affects the growth of the myelin sheath, has revealed measurable gains in motor and/or cognition skills, emphasizing the translational relevance of NPCs for treatment of white matter diseases (9) .
Although NPCs have been shown to migrate and facilitate remyelination in preclinical animal models of demyelination, the motility characteristics and interactions of NPCs with damaged axons have not directly been visualized in real time within the intact cord. Instead, imaging has been limited to "snapshots" of NPCs transplanted into the spinal cord and visualized in fixed tissue by immunohistochemistry or with fluorescently labeled engrafted cells (8, 10, 11) . In this study, we used a mouse model of viral-induced demyelination to establish an alternative imaging system enabling stable ex vivo imaging of transplanted GFPlabeled mouse NPCs within the ventral murine spinal cord through use of two-photon (2P) microscopy. Mice persistently infected with the neurotropic JHM strain of mouse hepatitis virus (JHMV) develop MS-like symptoms ranging from partial to complete hind limb paralysis that are associated with immune cell accumulation within the CNS and white matter damage (12) (13) (14) (15) (16) . We have previously demonstrated that engraftment of syngeneic mouse NPCs promotes clinical recovery that correlates with increased axonal integrity and remyelination (8) , although neuroinflammation is not affected (17) . Transplanted NPCs follow a CXCL12 chemokine gradient to preferentially colonize areas of white matter damage, where a majority of cells differentiate into an oligodendrocyte lineage (5, 8) .
Two-photon microscopy enables real-time visualization of cellular migration and intercellular interactions within intact organs (18) . Several groups have used 2P microscopy to characterize axonal degradation and immune cell dynamics in the Significance Stem cell transplantation has emerged as a promising cellbased therapy for the treatment of demyelinating diseases such as multiple sclerosis (MS). This study provides the first real-time imaging of transplanted stem cell-mediated remyelination in a mouse model of MS. Whereas current treatments solely delay disease progression, transplanted stem cells actively reverse clinical disease in animal models. Using two-photon microscopy and viral-induced demyelination, we describe a technique to visualize cellular migration and remyelination in the mouse spinal cord. Transplanted neural precursor cells physically wrap damaged axons with newly formed myelin, preserving axonal health.
dorsal spinal cord during demyelinating disease progression (19) (20) (21) (22) (23) . However, because engrafted NPCs preferentially migrate to regions deep within the ventral spinal cord (24) , standard dorsalside 2P in vivo imaging techniques are not suitable for visualization deep in the ventral side. Using a ventral-side imaging preparation, we now demonstrate that NPCs transplanted into the spinal cords of JHMV-infected mice under pathologic conditions migrate directionally, take up residence in regions of axonal degradation, colocalize with damaged axons, and facilitate remyelination through direct interactions with axons.
Results
Live-Cell Imaging of Axonal Degeneration in the Ventral Spinal Cord.
To establish a system for ex vivo imaging in the ventral side of the murine spinal cord, we isolated the spinal cord from thoracic vertebra 4 to lumbar vertebra 2. The explanted spinal cord was embedded in a 5% agarose gel to maintain spinal cord integrity during superfusion with oxygenated medium (Fig. 1A) and was subsequently imaged by 2P microscopy. We used transgenic Thy1-YFP mice, which express yellow fluorescent protein (YFP) in a subset of medium-to large-caliber axons (25, 26) , to study axonal pathology in the ventral spinal cord during the course of demyelination following JHMV infection. Lesions in the ventral spinal cord contained axons displaying a spectrum of "focal axonal degeneration" (FAD) [an established scale of axonal damage (20) ] morphologies (Fig. 1B) . Long, continuous axons with no damage are defined as "FAD stage 0"; FAD stage 1 axons contain focal swellings progressing along the length of the axon; and FAD stage 2 axons have gaps separating areas of YFP fluorescence. Analysis of FAD at various time points following JHMV infection revealed a progression of axonal pathology (Fig. 1C) , similar to studies examining FAD in the dorsal spinal cord following myelin oligodendrocyte glycoprotein (MOG) immunization (20) . Whereas damaged axons were not observed in the noninfected mouse (Fig. 1D) , rapid FAD progression was readily observed 7 d following JHMV infection, confirming that FAD was a result of JHMV infection ( Fig. 1E and Movie S1).
Whereas FAD has been shown to be associated with mitochondrial and myelin damage (20) , it is unknown whether FAD stage 2 axons are completely transected. To determine the extent of axonal transection in axons that had lost YFP signal, JHMVinfected spinal cord sections were examined for axonal damage by immunofluorescence microscopy of αSMI-32 staining, which detects a nonphosphorylated epitope in neurofilament H (27) . In areas where the axonal YFP signal was markedly diminished and fractured, SMI-32 staining appeared punctate or absent, indicating severely damaged axons ( Fig. 2A) . We observed various stages of axonal damage along the length of a single axon (Fig.  2B ), including areas of intact YFP signal without SMI-32 (intact healthy axon), YFP signal concomitant with SMI-32 (intact but damaged axon), no YFP or SMI-32 signal (transected area of axon without continuous neurofilament), and SMI-32 without YFP signal (intact but damaged axon). The latter case indicates that although a loss of YFP fluorescence correlates with varying degrees of axonal damage, it does not necessarily indicate complete axonal transection. We conclude that loss of YFP signal correlates with varying degrees of axonal damage, but not necessarily an irreversibly transected axon. Whereas both FAD 1 and FAD 2 axons had areas with axonal damage, axons exhibiting loss of both YFP and SMI32 at multiple loci were more common in FAD 2 axons (Fig. 2C) . To verify that axonal regions devoid of both YFP and SMI-32 signal are completely transected, we performed immunohistochemical staining for SMI-31, an accepted marker for undamaged axonal regions (phosphorylated neurofilament H) (28) . We were unable to detect SMI-31 without YFP signal along YFPexpressing axons (Fig. 2D ). These findings support the conclusion that YFP −
SMI-32
− axonal regions are transected.
Live-Cell Imaging of NPC Dynamics in the Ventral Spinal Cord. To observe engrafted NPC behavior, GFP-NPCs were transplanted intraspinally at thoracic vertebra 10 (5, 24, 29) and were monitored ex vivo under 2P excitation. We first confirmed that GFP-fluorescent cells were indeed NPCs and that the fluorescence did not arise from other cells that may have phagocytosed GFP-NPCs. Spinal cord slices were stained for the ionized calcium-binding adaptor molecule 1 (Iba-1), a marker of activated macrophages and microglia (30) . Despite a high number of activated macrophages and microglia in the spinal cord 3 wk following transplant, GFP fluorescence did not overlap with Iba-1 staining (Fig. 3A) , demonstrating that the GFP fluorescence observed in the spinal cord was not due to engulfed NPCs and this was consistent with earlier studies (5). At day 1 following GFP-NPC transplantation into a noninfected mouse, clusters of cells had limited motility at the site of transplant (Fig. S1A) . In control noninfected mice, GFP-NPCs moved with an average velocity of 1.9 ± 0.1 μm·min −1 (n = 5). NPC motility characteristics were altered in the JHMV-infected demyelinated spinal cord, where GFP-NPCs moved with a lower average velocity of 0.9 ± 0.05 μm·min −1 at the transplant site (n = 6) (Fig. S1B) . In contrast to the limited motility observed at the injection site, GFP-NPCs located 300 μm or farther from the transplant site were observed to move more rapidly in both infected and noninfected mice. (Fig. 3B and Movie S2). At day 1 posttransplant, GFP-NPCs were observed distal to the transplant site in three of five noninfected and three of six JHMV-infected mice. GFP-NPCs >300 μm from the transplant site had an average velocity of 5.0 ± 0.7 μm·min −1 in the JHMV-infected spinal cord, compared with 9.3 ± 0.6 μm·min −1 in the noninfected spinal cord (Fig. 3C ). We applied directional persistence analysis (31) to further characterize NPC migration to describe the direction of cell movement over time; a value of 1 represents migration along a straight line without turning, 0 represents neutral (Fig. 3C) .
When examined 14 d after transplant, GFP-NPCs were observed in dense clusters in the ventral area of the thoracic region of both the noninfected and the JHMV-infected spinal cord. A subset of GFP-NPCs expressed Ki-67, a nuclear marker of cellular proliferation (32), indicating proliferation occurred 2 wk after transplant (Fig. 4A) . Proliferation was significantly increased within the JHMV-infected spinal cord, in which 55.7 ± 6.8% of DAPI + GFP-NPCs expressed Ki-67, compared with 14.4 ± 2.2% in the noninfected spinal cord (Fig. 4B) . Two-photon imaging revealed that GFP-NPCs exhibit dynamic morphologies in the ventral spinal cord. Cells were observed to proliferate, with large (∼10 μm) "buds" protruding off clusters of GFP-NPCs ( Fig. 4C and Movie S3), and GFP-NPCs actively extended and retracted processes in both the noninfected and the JHMV-infected spinal cord ( Fig. S2 and Movie S4).
GFP-NPCs Preferentially Colocalize with Damaged Axons. One week following NPC transplantation into the JHMV-infected Thy1-YFP mouse, GFP-NPCs closely associated with stage 1 and stage 2 FAD axons ( Fig. 5 A and B) . Large clusters of GFP-NPCs preferentially established residence in regions with extensive axonal damage as determined by the FAD index (Fig. 5C) . Following migration to FAD lesions, GFP-NPCs initiated intercellular interactions with stage 1 and stage 2 FAD axons ( Fig.  5D and Movie S5), gathering YFP fluorescent segments of stage 2 axons together ( Fig. 5E and Movie S6). Because loss of YFP signal does not necessarily indicate a transected axon, GFP-NPC contact with an axon may alter YFP fluorescence within intact FAD axons. Therefore, we examined GFP-NPCs that transiently contacted Thy1-YFP axons at 2 wk posttransplant. Axonal pathology has been associated with a decrease in YFP fluorescence (20) , suggesting that NPC interactions with FAD axons may stabilize axons. In transient interactions, as the colocalization of an NPC and an axon diminished, YFP fluorescence rapidly decreased in the axon, changing the axon from FAD 1 to FAD 2 ( Fig. 6 A-C and Movie S7). Analysis of multiple GFP-NPCs revealed that the migration of NPCs away from damaged axons was strongly correlated with the loss of axonal YFP fluorescence (Fig. 6D) .
Engrafted GFP-NPCs Remyelinate Axons. To determine whether transplanted NPCs produce myelin following interactions with damaged axons, we cultured NPC neurospheres isolated from mice that express GFP under the control of the myelin proteolipid protein promoter (PLP-GFP) (33) . Two weeks following transfer into a JHMV-infected spinal cord, NPCs formed stable interactions with damaged axons and expressed GFP, indicating that transplanted NPCs differentiated into myelinating cells and expressed myelin genes (Fig. 7A) . In these cells, GFP fills the cytoplasm of the cell body, revealing that differentiated NPCs wrapped around damaged axons (Movie S8), with the GFP fluorescence extending around the length of the axon (Fig. 7B) . Correspondingly, YFP fluorescence increased (Fig. 7C) , indicating increased axonal health based on earlier reports correlating axonal health/integrity with YFP expression (20) . Furthermore, we found GFP-NPCs wrapped around YFP + axons and myelin basic protein (MBP) Overall mean is indicated in red (P < 0.0001). (D) Scatter plot of GFP-NPC directional persistence (dp) in the spinal cord (noninfected, dp = 0.62 ± 0.03; JHMV-infected, dp = 0.48 ± 0.04; P = 0.027). colocalized with GFP fluorescence, further confirming that transplanted NPCs actively participate in remyelination ( Fig. 7D and Fig. S3 ).
Discussion
Our results indicate that transplanted GFP-NPCs preferentially migrate to regions of axonal damage, proliferate, and actively remyelinate axons. NPCs have been shown to selectively colonize areas of white matter damage and facilitate remyelination in preclinical animal models of neuroinflammatory demyelination (5, 8, 34, 35) . However, the migration of transplanted NPCs and their interactions with damaged axons has not previously been visualized. In this study, we established a system for stable ex vivo imaging to observe single NPC behavior in the ventral spinal cords of mice, using a model of viral-induced demyelination. Although the etiology of MS is unknown, numerous factors including both genetic and environmental influences are considered important in initiation and maintenance of disease. Viral infection has long been considered a potential triggering mechanism involved in demyelination, and numerous human viral pathogens have been suggested to be involved in eliciting myelinreactive lymphocytes and/or antibodies that subsequently infiltrate the CNS and damage the myelin sheath (36-39). As such, viral models of neuroinflammation/demyelination are relevant and have provided important insights into mechanisms associated with disease. Moreover, the molecular mechanisms governing how engrafted NPCs interact with demyelinated axons within an inflammatory environment resulting from demyelination derived from a persistent viral infection have not been defined. Therefore, the present study uses the JHMV model of demyelination to characterize NPC migration kinetics as well as their ability to physically engage demyelinated axons and promote remyelination. To accomplish this, we used transgenic Thy1-YFP mice and 2P microscopy to visualize axonal damage following JHMV infection and imaged real-time interactions of transplanted GFP-NPCs with damaged axons, allowing insight into mechanisms by which transplanted NPCs contribute to amelioration of clinical and histopathological disease.
Axonal damage in MS is considered a secondary event that occurs following myelin loss in response to accumulation of myelinreactive lymphocytes within the CNS and this is supported by experimental autoimmune encephalomyelitis (EAE), an autoimmune model of neuroinflammation and demyelination. More recently, through use of viral models of demyelination as well as EAE, emerging evidence supports the possibility that axonal damage precedes demyelination (40) (41) (42) (43) (44) . Within 1 wk following infection of Thy1-YFP mice with JHMV, we observed axons with FAD, characterized by discontinuous YFP fluorescence, consistent with earlier reports describing axonopathy in JHMV-infected mice (41, 45) . Our findings indicate that axonal damage occurs early following JHMV infection of the CNS before robust immune-mediated demyelination. Previous in vivo imaging studies of the demyelinated spinal cord suggest that loss of fluorescence in axons indicates total axonal transection (20, 23) . However, we show that loss of YFP fluorescence can occur in an intact axon and does not necessarily mean axonal transection. Although it is possible a variety of cell types may interact with axonal segments, we show that axonal YFP fluorescence changes reversibly during and subsequent to interaction with transplanted NPCs, judged by colocalization with transplanted NPCs. The observed variability in the amount of axonal YFP fluorescence change may be a result of the extent of axonal damage at the time of interaction or the length of the imaging window. These results extend previous studies from our laboratory that demonstrated axonal sparing following NPC transplantation into JHMV-infected mice (8) .
Physical engagement of damaged axons by transplanted NPCs increases axonal YFP fluorescence, and disengagement of NPCs from axons rapidly diminishes YFP signal intensity. Loss of YFP fluorescence may occur in intact axons due to impaired microtubular transport (46) , axonal swelling resulting in retraction of proteins from damaged areas (47) , changes in reactive oxygen and nitrogen species that initiate mitochondrial pathology (48), or changes in ion channel expression (49) that do not allow for a favorable environment for YFP fluorescence. However, to account for the rapid changes in YFP fluorescence, we propose that interactions with NPCs may reverse acidification and diminish elevated internal calcium concentrations present in axons in inflammatory lesions through effects on NMDA receptors (23) or acid-sensing ion channels (50) . YFP fluorescence is particularly sensitive to acidic pH (51), indicating that restoration of normal physiological pH may underlie rapid increases in axonal YFP fluorescence observed during remyelination. Continued studies examining these possibilities are required to better understand the nature of axonal damage in response to CNS viral infection and the ability of NPCs to protect and repair damaged axons.
We have previously shown that transplanted GFP-NPCs preferentially colonize areas of demyelination and this positional migration is guided, in part, by expression of the chemokine receptor CXCR4 on transplanted NPCs that respond to enriched expression of the chemokine ligand CXCL12 that is enriched within areas of white matter pathology (5). However, the motility of engrafted NPCs was not examined. Our results support and extend those earlier findings by showing that NPCs recognize and directly interact with damaged axons. Further, we now demonstrate motility differences between NPCs transplanted into a demyelinated spinal cord and NPCs transplanted into a noninfected spinal cord. One day following transplant into the JHMVinfected spinal cord, the motility of GFP-NPCs was slower than in the absence of infection. This result may be due to GFP-NPCs initiating contact with demyelinated axons. In support of this, we demonstrate that transplanted GFP-NPCs extended processes and make extensive contacts with damaged axons. However, it is possible that reduced GFP-NPC motility is due to inflammatory signals in the JHMV-infected spinal cord. The molecular signals mediating this interaction are to this point undefined, although previous studies have clearly shown that NPCs are capable of expressing adhesion molecules that may engage axons (52) .
Engagement of damaged axons by transplanted GFP-NPCs is the first step in events leading to NPC differentiation and remyelination (53, 54) . We have previously shown that the majority of transplanted NPCs into JHMV-infected mice differentiate into oligodendroglia, the myelinating cells of the CNS supporting an important role for transplanted cells in participating in remyelination (5, 8) . Moreover, transplantation of NPCs lacking the transcription factor Olig1 into JHMV-infected mice results in diminished clinical and histologic recovery that correlates with altered lineage fate commitment as Olig1-deficient NPCs preferentially differentiate into astrocytes (55) . Until now, studies have shown that transplanted NPCs directly or indirectly contribute to endogenous remyelination (11, 55) , although evidence of direct remyelination Cell Culture, Reagents, and Transplantation. Enhanced green fluorescent protein-expressing NPCs (GFP-NPCs), derived from C57BL/6 mice, were cultured as previously described (24) . In addition, NPCs from PLP-GFP mice were isolated and cultured before transplantation as previously described (34, 55) . Following culture in DMEM:F12 (Invitrogen) supplemented with 1× B27 (Invitrogen), 1× insulin-transferrin-selenium (Invitrogen), 1× penicillin-streptomycin (Invitrogen), 40 ng/mL T3 (Sigma-T67407), and 20 ng/mL human recombinant EGF (Sigma-E9644) for 5 d, PLP-GFP neurospheres were dissociated with 1× TrypLE (Gibco-12563-011) for 20 min at 37°C and centrifuged for 5 min at 500 × g, 4°C. Cells were resuspended and triturated in 1× HBSS followed by three washes with 1× HBSS. Undifferentiated GFP-NPCs or PLP-GFP-NPCs were transplanted (2.5 × 10 5 in 2.5 μL HBSS per mouse) at spinal cord T10 at day 14 p.i. into C57BL/6 and Thy1-YFP mice. As previously published, this time point for transplantation was chosen because virus and inflammation have waned whereas demyelination has peaked (5).
Spinal Cord Preparation, Two-Photon Imaging, and Analysis. Two-photon imaging was performed using a previously described system (56) with a Chameleon Ultra II Ti:Sapphire laser (Coherent). Spinal cords were isolated from thoracic vertebra 4 to lumbar vertebra 2, embedded in a 5% agarose gel to maintain the integrity of the spinal cord, oriented with the ventral side facing the dipping objective, and superfused with warmed, oxygenated medium as applied for ex vivo imaging of other explanted organs (56) . Explanted spinal cords were imaged with a laser excitation of 900 nm. Five hundred twenty-and 560-nm dichroic mirrors (Semrock) separated emission into blue (<520 nm), green (520-560 nm), and red (>560 nm) channels. Imaging volumes of x = 270 μm, y =212 μm, and z = 100 μm were acquired using Slidebook version 4.2 and 3D stacks were compiled in Metamorph version 6.1 (Molecular Devices). Imaging analysis was performed in Imaris version 7.3 (Bitplane). Increased power to the blue channel photomultiplier tube and Gaussian filtering were applied to improve visual separation of eGFP and eYFP. In final videos, cells were pseudocolored to enhance color separation between eYFP and eGFP. To calculate directional persistence we used the equation dp = ðD 2 
where D equals displacement and d equals distance, which was calculated every two steps for sequential 3D coordinates of cell position (31) . FAD index of MS-like lesions was calculated based on an axonal degradation index previously described (20) :
FAD index = ½ð# of stage 1 axons · 1Þ + ð# of stage 2 axons · 2Þ # axons :
Immunohistochemistry. The murine spinal cord was extracted and processed for optimal cutting temperature compound and resin-embedded sections as previously described (8) . For immunofluorescence staining, slides were prepared and blocked with goat serum in 1× PBS + 0.5% BSA as previously described (8) . Primary antibodies included rabbit anti-Iba1 (1 mg/mL; Wako Chemicals), rabbit anti-MBP (1:200; Chemicon), mouse anti-SMI-31 (phosphorylated neurofilament H; 1:1,000; EMD Millipore), or mouse anti-SMI-32 (nonphosphorylated neurofilament H; 1:1,000; Covance). Anti-SMI-31 and anti-SMI-32 were blocked as described above with the addition of 5% (vol/vol) purified goat anti-mouse IgG (Invitrogen). The secondary antibody used for anti-Iba1 and anti-MBP was Alexa 594 goat anti-rabbit (1:1,000; Invitrogen); for anti-SMI-31 and anti-SMI-32, Alexa 594 goat anti-mouse (1:1,000; Invitrogen) was used. DAPI Fluoromount-G (Southern Biotech) was used to visualize nuclei. Colocalization of overlapping fluorescence was determined using Imaris 7.3 (Bitplane). Pixel intensities over a set threshold at the same position were considered colocalized.
Statistical Analysis. Statistical significance for velocity measurements in Fig.  3C was determined using Student's t test. The Mann-Whitney U test was used to calculate significance for the nonnormally distributed directional persistence measurements in Fig. 3D . A P value <0.05 was considered significant. Data are presented as mean ± SEM.
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